Afrezza (MNKD) Cash per Share

Corporate emblem and logo of mannkindcorp.com (MNKD)

MannKind Corporation (MNKD) faces risks associated with the need for continuous R&D funding to retain bioengineers. The current cash per share level on GURU.Markets reflects stability, where the 0.30 mark serves as the current indicator. This situation is balanced by low staff turnover among inhalation experts and high loyalty from diabetics toward patented insulin delivery methods, which ensure long-term demand.

Afrezza (MNKD) Cash Funds per Share: for the period 07/04/2022 - 11/20/2026

Analytical breakdowns for MannKind (MNKD)

- current price and projected stock value:
- cash position and cash flow details:
Summary company analysis:MNKD Afrezza
Product sample of mannkindcorp.com

MannKind Corporation (MNKD) maintains a liquid reserve that ensures resilience against market volatility, mitigating the risks of component supply chain disruptions from Asia for its inhalation systems. By analyzing the average cash per share, an investor assesses the net cash cushion per security, where an increase in this metric minimizes the risk of a price collapse, while excess capital signals an inefficient use of development resources.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Single Share AMPH (Amphastar)|PCRX - Cash on Hand per Share|Cash per Share SPRY (ars-pharma.com)|Amount of Cash per Share TBPH|Aquestive Therapeutics, Inc. - Cash per Share|scpharmaceuticals.com - Cash Calculated per Single Share|Tectonic (TECX) - Cash Funds per Share|Cash per Single Share Tonix Pharmaceuticals Inc.|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)